Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease
Journal of the Peripheral Nervous System · 2025
DOI: 10.1111/jns.70081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Ah Jin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Kongju National University, Chungnam, Korea. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Mutation. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Research Foundation, Ministry of Health and Welfare, Ministry of Science and ICT and Ministry of Health and Welfare.
Abstract (Originalsprache)
Background and Aims De novo mutations provide a fundamental source of gene pool changes, driving genomic microevolution. Charcot–Marie–Tooth disease (CMT), which is a group of genetically and clinically heterogeneous peripheral neuropathic disorders, is characterized by progressive muscle weakness, hand and foot deformities, and occasional involvement of other organs. This study conducted the first cohort study of de novo mutations in CMT patients.
Methods
De novo mutations were examined in 151 genetically diagnosed father–mother–child trio autosomal dominant CMT families except for CMT1A.
Results
We identified 49 de novo point or small indel mutations in 61 patients. The frequency of de novo mutations was 40.4%, with gene‐specific rates in their distribution. Haplotype analysis revealed predominant paternal origin, consistent with previous reports for CMT1A. Frequent substitutions at highly methylated CpG sites suggested that CpG methylation strongly contributes to the induction of de novo mutations. In particular, this study observed an anticipation of earlier onset in the affected children compared to their parents (founders) with de novo mutations.
Interpretation
This study reports de novo mutations that occur frequently in CMT families. Characterization of de novo pathogenic mutations is expected to provide valuable insights not only into the genetic diagnosis and treatment of rare genetic diseases, but also into the evolutionary genomic study of deleterious alleles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, Kongju National University, Chungnam, Korea.
- Cell & Gene Therapy Institute, Samsung Medical Center, Seoul, Korea.
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Physics Education, Kongju National University, Chungnam, Korea.
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
- Center for Biotechnology, Kongju National University, Chungnam, Korea.
ORCID-Profile: Ki Wha Chung
Förderung
- National Research Foundation
- Ministry of Health and Welfare
- Ministry of Science and ICT and Ministry of Health and Welfare
Zitieren
APA
Lee, A. J., Nam, S. H., Lee, S., Lee, S. M., Lee, K. S., Choi, B. O., & Chung, K. W. (2025). Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70081
Vancouver
Lee AJ, Nam SH, Lee S, Lee SM, Lee KS, Choi BO, et al. Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70081
BibTeX
@article{Lee2025,
author = {Lee, Ah Jin and Nam, Soo Hyun and Lee, Sinyeong and Lee, Su Min and Lee, Kyung Suk and Choi, Byung-Ok and Chung, Ki Wha},
title = {Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
doi = {10.1111/jns.70081}
}
EUVIMED